Search
moon
sun

T71. Acute abdominal pain

A. Pathophysiology

A1. Visceral pain

โ€ข
ํ์ƒ‰, ๊ฒฝ์ƒ‰, ์—ผ์ฆ์€ unmyelinated fiber๋ฅผ ๋Š˜๋ฆฌ๋ฏ€๋กœ visceral pain์ด ๋ฐœ์ƒํ•œ๋‹ค. (์ฅ์–ด์งœ๊ฑฐ๋‚˜, ์นผ๋กœ ๋ฒ ๋Š” ๋“ฏํ•œ, ๋‘”ํ•œ ์–‘์ƒ)
โ€ข
๋ฐœ์ƒ๊ณ„ํ†ต์— ๋”ฐ๋ฅธ spinal cord level์˜ sensory cortex๋ฅผ ํ†ตํ•ด ์œ„์น˜๋ฅผ ์˜ˆ์ธกํ•  ์ˆ˜ ์žˆ๋‹ค. ex) Appendix - t10

A2. Parietal pain

โ€ข
Parietal peritoneum์„ innervationํ•˜๋Š” myelinated fiber์˜ ์ž๊ทน์œผ๋กœ ๋ฐœ์ƒํ•œ๋‹ค.
โ€ข
Visceral๊ณผ ๋‹ค๋ฅด๊ฒŒ, superficial dermatome์„ ํ†ตํ•ด ์œ„์น˜๋ฅผ ์˜ˆ์ธกํ•  ์ˆ˜ ์žˆ๋‹ค.

A3. Referred pain (๋ฐฉ์‚ฌํ†ต)

โ€ข
๋ฐฉ์‚ฌํ†ต์€ ๋ฐœ์ƒํ•™์—์„œ ์—ฐ๊ด€๋œ ์žฅ๊ธฐ๋ผ๋ฆฌ ์ผ์–ด๋‚  ์ˆ˜ ์žˆ๋‹ค.

B. Clinical features

B1. Clinical risk

(1) Patient acuity

โ€ข
์ž„์ƒ์ ์œผ๋กœ ์ค‘ํ™˜์ด ์˜์‹ฌ๋˜๋ฉด ์ฆ‰์‹œ ์•ˆ์ •ํ™” ์‹œ์ผœ์•ผ ํ•œ๋‹ค.
โ€ข
๊ณ ๋ น, ๊ฐ‘์ž๊ธฐ ๋ฐœ์ƒํ•œ ์‹ฌํ•œ ํ†ต์ฆ, ๋น„์ •์ƒ ํ™œ๋ ฅ์ง•ํ›„, ํƒˆ์ˆ˜, ์ฐฝ๋ฐฑ, ์‹์€๋•€, ํ† ํ•จ ๋“ฑ์˜ ์ฆ์ƒ์ด ์žˆ๋Š” ๊ฒฝ์šฐ ์ค‘ํ™˜์ผ ๊ฐ€๋Šฅ์„ฑ์ด ์žˆ๋‹ค.
โ€ข
Volume depletion์ผ ๊ฒฝ์šฐ ํ˜ˆ์••์€ ์ •์ƒ์ผ ์ˆ˜ ์žˆ๊ณ , tachycardia๊ฐ€ ์ค‘์š”ํ•œ ์ง€ํ‘œ๊ฐ€ ๋  ์ˆ˜ ์žˆ๋‹ค.
โ€ข
Normal blood volume์˜ 30%~40%๊นŒ์ง€ ๊ฐ์†Œ๋˜๊ธฐ ์ „๊นŒ์ง€๋Š” ์ˆ˜์ถ•๊ธฐ ํ˜ˆ์••์€ ์œ ์ง€๋  ์ˆ˜ ์žˆ๋‹ค.
โ€ข
์ฒด์˜จ์€ ํ™˜์ž์˜ condition์„ ํŒ๋‹จํ•˜๋Š” ๋ฐ ์žˆ์–ด์„œ ํฌ๊ฒŒ ๋„์›€๋˜์ง€ ์•Š๋Š”๋‹ค.

(2) Resuscitation

โ€ข
Cardiac monitor
โ€ข
Oxygen (2 to 4L/min via nasal cannula or mask)
โ€ข
Large-bore IV access, and an isotonic fluid bolus
โ€ข
AAA๋ฅผ ๊ฐ๋ณ„ํ•˜๊ธฐ ์œ„ํ•ด bedside US๋ฅผ ์‹œํ–‰ํ•˜๊ณ , ๔€ €๊ฐ• ๋‚ด ์ถœํ˜ˆ์ด ์˜์‹ฌ๋˜๋Š” ๊ฒฝ์šฐ์—๋Š” FAST ํ™•์ธ

(3) Risk factors

โ€ข
AIDS ํ™˜์ž์—์„œ CD4 counts๊ฐ€ 200/mm3์„ ๋„˜์œผ๋ฉด ๊ธฐํšŒ๊ฐ์—ผ์˜ ๊ฐ€๋Šฅ์„ฑ์€ ๊ฑฐ์˜ ์—†๋‹ค.

B2. Physical examination

(1) ํ†ต์ฆ์— ๋Œ€ํ•ด PPQRSTT๋ฅผ ํ™•์ธํ•œ๋‹ค.

โ€ข
Provocative/Palliative factors
โ€ข
Quality
โ€ข
Radiation
โ€ข
associated Symptoms
โ€ข
Timing
โ€ข
what the patient has Taken for the pain

C. Sx. Tx. and further clinical diagnosis

โ€ข
์ฆ์ƒ์˜ ์™„ํ™”๋ฅผ ๋จผ์ € ํ•ด์•ผ ํ•œ๋‹ค.
โ€ข
Opioid๋Š” abdominal findings๋ฅผ ๋ชจํ˜ธํ•˜๊ฒŒ ํ•˜์ง€ ์•Š์„ ๋ฟ๋”๋Ÿฌ ์ง„๋‹จ์„ ๋Šฆ์ถ”๊ฑฐ๋‚˜ ํ˜น์€ morbidity๋‚˜ mortality๋ฅผ ์ฆ๊ฐ€์‹œํ‚ค์ง€ ์•Š๋Š”๋‹ค.
โ€ข
Ondansetron์ด๋‚˜ metoclopramide ๊ฐ™์€ ํ•ญ๊ตฌํ† ์ œ์˜ ํˆฌ์—ฌ ๋˜ํ•œ ํ•„์š”ํ•˜๋‹ค.
โ€ข
NG tube foley catheter ๊ฑฐ์น˜์— ๋Œ€ํ•ด์„œ๋„ ๊ณ ๋ ค๋ฅผ ํ•ด์•ผ ํ•œ๋‹ค.

C1. Laboratory testing

โ€ข
ํ˜ˆ์•ก๊ฒ€์‚ฌ ๊ฒฐ๊ณผ๋Š” ์ฐฉ์‹คํ•œ history taking๊ณผ P/Ex์„ ๋Œ€์‹ ํ•˜์ง€ ์•Š์„๋ฟ๋”๋Ÿฌ โ€œroutine abdominal labsโ€ ๋ผ๋Š” ๊ฒƒ์˜ ์œ ์šฉ์„ฑ์— ๋Œ€ํ•œ ๊ฒ€์ฆ์€ ์—†๋‹ค.
โ€ข
๋ฐฑํ˜ˆ๊ตฌ ์ˆ˜์น˜ ๋‹จ๋…์€ ์‹ฌ๊ฐํ•œ ์งˆํ™˜์ด๋‚˜ surgical abdomen์„ rule out ํ•ด์ฃผ์ง€ ์•Š๋Š”๋‹ค.
โ€ข
๋งŒ์ผ serum creatinine >1.5 ํ˜น์€ GFR <60์ธ ๊ฒฝ์šฐ life-threateningํ•œ ๊ฒฝ์šฐ๋ฅผ ์ œ์™ธํ•˜๊ณ ๋Š” IV contrast๋Š” ์ถ”์ฒœ๋˜์ง€ ์•Š๋Š”๋‹ค.

(1) Suggested lab studies for goal-directed clinical testing in abdominal pain

Table 71-3
โ€ข
Amylase : Pancreatitis (if lipase not available)
โ€ข
Lipase : Pancreatitis
โ€ข
ฮฒ-hCG : Pregnancy, ectopic or molar pregnancy
โ€ข
Coagulation studies : GI bleeding, end-stage liver disease, coagulopathy
โ€ข
Electrolytes : Dehydration, endocrine or metabolic disorder
โ€ข
Glucose : Diabetic ketoacidosis, pancreatitis
โ€ข
Gonococcal/chlamydia testing : Cervicitis/urethritis, pelvic inflammatory disease
โ€ข
Hemoglobin : GI bleeding
โ€ข
Lactate : Mesenteric ischemia, sepsis
โ€ข
Liver function test : Cholecystitis, cholelithiasis, hepatitis
โ€ข
Platelets : GI bleeding
โ€ข
Renal function tests : Dehydration, renal insufficiency, acute renal failure
โ€ข
Urinalysis : Urinary tract infection, pyelonephritis, nephrolithiasis
โ€ข
ECG : myocardial ischemia or infarction

D. Diagnostic imaging

โ€ข
์ด๋ฏธ์ง€ study ์—ญ์‹œ history์™€ physical exam์„ ๋Œ€์‹ ํ•˜์ง€ ๋ชปํ•œ๋‹ค. ๋ชจ๋“  ๋ณตํ†ต์ด ์˜์ƒ ๊ฒ€์‚ฌ๋ฅผ ํ•„์š”๋กœ ํ•˜๋Š” ๊ฒƒ์€ ์•„๋‹ˆ๋‹ค.

D1. ์ดˆ์ŒํŒŒ

โ€ข
์„ฑ์ธ์—์„œ ๋‹ด๋‚ญ, ์ทŒ์žฅ, ์ฝฉํŒฅ, ์š”๋กœ, ๋ฐฉ๊ด‘์˜ ์šฉ์ , ๋Œ€๋™๋งฅ์˜ ์ง๊ฒฝ์„ ์žฌ๋Š”๋ฐ ๋„์›€ ๋œ๋‹ค.
โ€ข
์†Œ์žฅ, ๋Œ€์žฅ ์งˆํ™˜์—๋Š” ๋„์›€์ด ๋˜์ง€ ์•Š๋Š”๋‹ค.

D2. APCT

โ€ข
๋งŒ์ผ serum creatinine >1.5 ํ˜น์€ GFR <60 ์ธ ๊ฒฝ์šฐ life-threateningํ•œ ๊ฒฝ์šฐ๋ฅผ ์ œ์™ธํ•˜๊ณ ๋Š” IV contrast๋Š” ์ถ”์ฒœ๋˜์ง€ ์•Š๋Š”๋‹ค.
โ€ข
AAA rupture or mesenteric ischemia๊ฐ€ ์˜์‹ฌ๋˜๋Š” ํ™˜์ž์— ์žˆ์–ด์„œ๋Š” initial test of choice์ด๋‹ค.

E. Treatment

E1. Antibiotics

โ€ข
๋ณต๊ฐ• ๋‚ด ํŒจํ˜ˆ์ฆ, panperitonitis์—์„œ ์‚ฌ์šฉํ•  ์ˆ˜ ์žˆ๋‹ค.
โ€ข
์‚ฐ๋ถ€์ธ๊ณผ์ ์ธ ์›์ธ์„ ์ œ์™ธํ•œ ๋ชจ๋“  ๋ณต๊ฐ• ๋‚ด ๊ฐ์—ผ์€ ํ˜๊ธฐ์„ฑ๊ท ๊ณผ G(-) ํ˜ธ๊ธฐ์„ฑ๊ท ์„ coverํ•ด์•ผ ํ•œ๋‹ค.

E2. Dyspepsia ๋‚˜ Non-specific abdominal painํ™˜์ž์—์„œ ํ‡ด์›์•ฝ

์‘๊ธ‰์‹ค์—์„œ ์‘๊ธ‰์›์ธ(์™ธ๊ณผ์ /ํ˜ˆ์—ญํ•™์ /์‹ฌ๊ทผํ—ˆํ˜ˆ ๋“ฑ)์„ ์ถฉ๋ถ„ํžˆ ๋ฐฐ์ œํ•œ ๋’ค, ๊ธฐ๋Šฅ์„ฑ/๋น„ํŠน์ด์ ์œผ๋กœ ๋ณด์ด๋Š” acute dyspepsia ๋˜๋Š” non-specific abdominal pain ํ™˜์ž๋ฅผ ํ‡ด์›์‹œํ‚ค๋Š” ์ƒํ™ฉ์„ ์ „์ œ๋กœ ์ •๋ฆฌํ•œ๋‹ค.canadiem+1

(1) ๊ธฐ๋ณธ ์›์น™

โ€ข
๊ฐ€๋Šฅํ•œ ํ•œ ๋‹จ๊ธฐ ์ฒ˜๋ฐฉ(๋ณดํ†ต 3โ€“7์ผ) + ์ฆ์ƒ ํ˜ธ์ „/์•…ํ™” ์‹œ ๋ช…ํ™•ํ•œ FU ํ”Œ๋žœ.
โ€ข
์˜คํ”ผ์˜ค์ด๋“œ๋Š” ๊ฐ€๊ธ‰์  ํ”ผํ•˜๊ณ , ํ•„์š” ์‹œ์—๋„ ์ตœ์†Œ ์šฉ๋Ÿ‰ยท๋‹จ๊ธฐ๋งŒ ์‚ฌ์šฉ.pmc.ncbi.nlm.nih
โ€ข
red flag(๋ฐœ์—ด, ์ฒด์ค‘๊ฐ์†Œ, ์ง€์†/์•…ํ™”ํ•˜๋Š” ํ†ต์ฆ, ํ† ํ˜ˆ/ํ‘์ƒ‰๋ณ€, ํ™ฉ๋‹ฌ, ์‹ฌํ•œ ์••ํ†ต/๋ฐ˜๋ฐœํ†ต ๋“ฑ) ๋ฐœ์ƒ ์‹œ ์ฆ‰์‹œ ์žฌ๋‚ด์› ๊ต์œก.

(2) 1์ฐจ ์„ ํƒ: ์œ„์‚ฐ ๊ด€๋ จ ์ฆ์ƒ(heartburn/epigastric burning ์ค‘์‹ฌ)

์ฆ์ƒ์ด ๋ช…๋ฐฑํžˆ ์‚ฐ์—ญ๋ฅ˜/์†์“ฐ๋ฆผ ์œ„์ฃผ๋ผ๋ฉด acid suppression์„ ์ค‘์‹ฌ์œผ๋กœ ์ฒ˜๋ฐฉํ•œ๋‹ค.
1.
์†ํšจ์„ฑ ์ฆ์ƒ ์กฐ์ ˆ: ์ œ์‚ฐ์ œ PRN
โ€ข
์•Œ๋ฃจ๋ฏธ๋Š„/๋งˆ๊ทธ๋„ค์Š˜ ์ œ์‚ฐ์ œ ํ˜„ํƒ์•ก ๋˜๋Š” chewable tab PRN (์‹ํ›„ยท์ทจ์นจ ์ „, ์ƒํ•œ ์šฉ๋Ÿ‰ ๋‚ด).
โ€ข
ED ์—ฐ๊ตฌ์—์„œ ๊ธ‰์„ฑ ์œ„ํ†ตยท์ƒ๋ณต๋ถ€ํ†ต์— antacid ๋‹จ๋…์ด GI cocktail์ด๋‚˜ IV PPI๋ณด๋‹ค ๋‹จ๊ธฐ ํ†ต์ฆ ์กฐ์ ˆ์ด ๋น ๋ฅธ ๊ฒƒ์œผ๋กœ ๋ณด๊ณ .tamingthesru+2
1.
์ง€์† ์ฆ์ƒ ์˜ˆ๋ฐฉ: PPI ๋˜๋Š” H2 blocker
โ€ข
PPI (์˜ˆ: omeprazole 20 mg qd, esomeprazole 20 mg qd, pantoprazole 40 mg qd, 2โ€“4์ฃผ):
โ—ฆ
๊ธฐ๋Šฅ์„ฑ/๋ฏธ์กฐ์‚ฌ dyspepsia์—์„œ 1์ฐจ ์•ฝ์ œ๋กœ ๊ถŒ๊ณ ๋˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ๊ณ , H2RA๋ณด๋‹ค ์ฆ์ƒ ๊ฐœ์„ ๋ฅ ์ด ์•ฝ๊ฐ„ ์šฐ์›”.gut.bmj+1
โ€ข
H2 blocker (์˜ˆ: famotidine 20 mg bid, 1โ€“2์ฃผ):
โ—ฆ
onset์ด ๋น„๊ต์  ๋น ๋ฅด๊ณ  12์‹œ๊ฐ„ ์ •๋„ acid suppression, ๋‹จ๊ธฐ use์— ์ ํ•ฉ.pepcid+1
โ€ข
ED setting์—์„œ๋Š”:
โ—ฆ
ํ‡ด์›์•ฝ์œผ๋กœ๋Š” PPI qd 2์ฃผ + ํ•„์š” ์‹œ ์ œ์‚ฐ์ œ PRN ์กฐํ•ฉ์ด ์‹ค์šฉ์ .
โ—ฆ
์•ผ๊ฐ„ heartburn ์œ„์ฃผยท์ฆ์ƒ ๊ฒฝํ•œ ๊ฒฝ์šฐ famotidine 20 mg hs ๋˜๋Š” bid + ์ œ์‚ฐ์ œ PRN ๋„ ๋ฌด๋‚œ.

(3) ์ƒ๋ณต๋ถ€ ํŒฝ๋งŒ/์กฐ๊ธฐ๋งŒ๋ณต/๋น„ํŠน์ด์  ์†Œํ™”๋ถˆ๋Ÿ‰ ์œ„์ฃผ์ผ ๋•Œ

โ€ข
dysmotility-like functional dyspepsia์—์„œ๋Š” PPI ๋‹จ๋…์ด H2RA + prokinetic๋ณด๋‹ค ์šฐ์›”ํ–ˆ๋‹ค๋Š” ์—ฐ๊ตฌ๋„ ์žˆ์–ด PPI๋ฅผ ์—ฌ์ „ํžˆ 1์ฐจ๋กœ ๋ณผ ์ˆ˜ ์žˆ๋‹ค.pmc.ncbi.nlm.nih
โ€ข
๊ทธ๋ž˜๋„ ์ž„์ƒ์—์„œ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™์€ ์กฐํ•ฉ์ด ํ”ํ•จ:
โ—ฆ
PPI qd (๋˜๋Š” famotidine bid)
โ—ฆ
์†์“ฐ๋ฆผ๋ณด๋‹ค๋Š” ๋”๋ถ€๋ฃฉํ•จ, ์กฐ๊ธฐ๋งŒ๋ณต์ด prominentํ•  ๋•Œ domperidone, itopride ๋“ฑ prokinetic์„ ๋‹จ๊ธฐ(1โ€“2์ฃผ) ๋ณ‘์šฉ (๊ธˆ๊ธฐ: QT, ํŒŒํ‚จ์Šจ, ๊ณ ๋ น ๋“ฑ ๊ฐœ๋ณ„ ๊ณ ๋ ค).

(4) non-specific abdominal pain (์›์ธ ๋ฏธํ™•์ •, ๊ฒฝ์ฆยท์‚ฐํ†ตํ˜•)

๊ตฌ์ฒด์  ์ง„๋‹จ์ด ์•ˆ ๋‚˜์˜ค์ง€๋งŒ ๊ฒ€์‚ฌ์ƒ ์œ„ํ—˜์†Œ๊ฒฌ ์—†๊ณ , ๊ฒฝ์ฆ ๋ณตํ†ต/์ฅ์–ด์งœ๋Š” ์–‘์ƒ์ธ ๊ฒฝ์šฐ:
โ€ข
1์ฐจ ์ง„ํ†ต:
โ—ฆ
PO acetaminophen 500โ€“1000 mg q6h PRN (max 3โ€“4 g/day) ยฑ ์งง์€ ๊ธฐ๊ฐ„ NSAID (์œ„์—ผ/์‹ ์žฅ ์œ„ํ—˜ ๊ณ ๋ ค). ์ผ๋ฐ˜ ED ํ†ต์ฆ ๋ฆฌ๋ทฐ์—์„œ๋„ NSAID/acetaminophen์ด ์ผ์ฐจ ์„ ํƒ์œผ๋กœ ์ œ์‹œ
โ—ฆ
๊ฒฝ๋ จ์„ฑ ๋ณตํ†ต์ด ๋šœ๋ ทํ•˜๋ฉด: butylscopolamine, mebeverine ๋“ฑ ์ง„๊ฒฝ์ œ๋ฅผ ์งง๊ฒŒ PRN ์ฒ˜๋ฐฉ (ํŠนํžˆ IBS-like crampy pain).
โ€ข
๋™์‹œ์— ์œ„์žฅ๊ด€ ์›์ธ ๊ฐ€๋Šฅ์„ฑ์ด ๋†’์œผ๋ฉด ์œ„์˜ PPI/H2RA ยฑ ์ œ์‚ฐ์ œ ์ค‘ ํ•˜๋‚˜๋ฅผ ์ถ”๊ฐ€.

(5) ED์—์„œ ํ”ผํ•˜๊ฑฐ๋‚˜ ์กฐ์‹ฌํ•  ์•ฝ์ œ

โ€ข
viscous lidocaine + antacid + antispasmodic โ€œGI cocktailโ€
โ—ฆ
์ œ์‚ฐ์ œ ๋‹จ๋…๋ณด๋‹ค ์šฐ์›”ํ•œ ์ด๋“์ด ์—†๊ณ , aspirationยท๋งˆ๋น„์„ฑ ์žฅํ์ƒ‰ ๋“ฑ ์ž ์žฌ ์œ„ํ—˜์œผ๋กœ ์ธํ•ด routine ์‚ฌ์šฉ ๋น„๊ถŒ์žฅ.canadiem+1
โ€ข
์žฅ๊ธฐ PPI ์œ ์ง€
โ—ฆ
๋‹จ๊ธฐ ํ‡ด์› ์ฒ˜๋ฐฉ(2โ€“4์ฃผ ํ›„ ์žฌํ‰๊ฐ€) ์—†์ด ์Šต๊ด€์ ์œผ๋กœ ๊ณ„์† ์—ฐ์žฅ๋˜๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์•„, ํ‡ด์› ์‹œ ์ด๋ฏธ ์ข…๋ฃŒ ์‹œ์ ยท์ถ”์  ๊ณ„ํš์„ ๋ช…์‹œํ•˜๋Š” ๊ฒƒ์ด ์ข‹๋‹ค.scielo.isciii
โ€ข
์˜คํ”ผ์˜ค์ด๋“œ
โ—ฆ
๋น„ํŠน์ด ๋ณตํ†ต์—์„œ ์˜คํ”ผ์˜ค์ด๋“œ๋Š” ์ง„๋‹จ์„ ๊ฐ€๋ฆฌ๊ณ  ileusยท๋ณ€๋น„ยท๊ตฌ์—ญ์„ ์•…ํ™”์‹œํ‚ค๋ฏ€๋กœ, ๊ตฌ์กฐ์  ์งˆํ™˜์ด ๋ช…ํ™•ํ•˜๊ฑฐ๋‚˜ ์ค‘๋“ฑ๋„โ€“์ค‘์ฆ ํ†ต์ฆ์—์„œ ๋‹ค๋ฅธ ์˜ต์…˜ ์‹คํŒจ ์‹œ์—๋งŒ ์ œํ•œ์ ์œผ๋กœ.pmc.ncbi.nlm.nih

(6) ์‹ค์ „์šฉ ์˜ˆ์‹œ ๋ ˆ์ง€๋ฉ˜ (์„ฑ์ธ, ๊ตฌ์กฐ์  ์งˆํ™˜ ๋ฐฐ์ œ๋œ ๊ฒฝ์šฐ)

โ€ข
acute dyspepsia (heartburn/epigastric pain ์šฐ์„ธ)
โ—ฆ
PPI: pantoprazole 40 mg PO qd ร— 14์ผ
โ—ฆ
์ œ์‚ฐ์ œ ํ˜„ํƒ์•ก 10โ€“20 mL PO q6h PRN
โ—ฆ
ํ•„์š” ์‹œ acetaminophen 500โ€“1000 mg PO q6h PRN ๋ณตํ†ต
โ€ข
์œ„ํŒฝ๋งŒ/๋”๋ถ€๋ฃฉํ•จยท์กฐ๊ธฐ๋งŒ๋ณต ์šฐ์„ธ, ๊ฒ€์‚ฌ์ƒ ์ด์ƒ ์—†์Œ
โ—ฆ
PPI: esomeprazole 20 mg PO qd ร— 14์ผ
โ—ฆ
ยฑ prokinetic (์˜ˆ: itopride 50 mg PO tid AC ร— 7โ€“14์ผ, ๊ฐœ๋ณ„ ๊ธˆ๊ธฐ ๊ณ ๋ ค)
โ€ข
non-specific mild abdominal pain, IBS-like cramp
โ—ฆ
acetaminophen 500โ€“1000 mg PO q6h PRN
โ—ฆ
butylscopolamine 10โ€“20 mg PO tid PRN (1์ฃผ ์ด๋‚ด)
โ—ฆ
ยฑ famotidine 20 mg PO bid ร— 7์ผ (์ƒ๋ณต๋ถ€ ๋ถˆํŽธ๊ฐ ๋™๋ฐ˜ ์‹œ)
์ด ์ •๋„ ํ‹€ ์•ˆ์—์„œ ํ™˜์ž ์—ฐ๋ น, ๊ธฐ์ €์งˆํ™˜(์‹ ์žฅ/๊ฐ„์งˆํ™˜, ์ถœํ˜ˆ์œ„ํ—˜, QT, ํŒŒํ‚จ์Šจ ๋“ฑ), ํ˜„์žฌ ๋ณต์šฉ์•ฝ์„ ๊ณ ๋ คํ•ด ์กฐ์ •ํ•˜๋ฉด ์‘๊ธ‰์‹ค ํ‡ด์›์•ฝ์œผ๋กœ ๋ฌด๋‚œํ•˜๊ฒŒ ์‚ฌ์šฉํ•  ์ˆ˜ ์žˆ๋‹ค.

F. Disposition and follow-up

โ€ข
CT ๊ฒ€์‚ฌ ์ƒ์—์„œ ํŠน์ด ์†Œ๊ฒฌ์ด ๋ณด์ด์ง€ ์•Š์•˜๋‹ค๊ณ  ํ•˜๋”๋ผ๋„ ํ‡ด์› ์‹œ ์ง„๋‹จ์ด ๋ช…ํ™•ํ•˜์ง€ ์•Š์€ ๊ฒฝ์šฐ 12์‹œ๊ฐ„ ์ด๋‚ด์— ๋‹ค์‹œ ์žฌ๋‚ด์›ํ•˜๋„๋ก ๊ต์œกํ•ด์•ผ ํ•œ๋‹ค (Tq ์™ธ๋ž˜์—์„œ ๋ฐ›์•„์ค˜์•ผ ๋ง์ด์ง€).

G. Special populations

G1. Women

โ€ข
์ž๊ถ์ ˆ์ œ์ˆ ์„ ํ•˜์ง€ ์•Š์€ ๊ฐ€์ž„๊ธฐ์˜ ๊ธ‰์„ฑ ๋ณตํ†ต ํ™˜์ž์—์„œ๋Š” ์ •๋Ÿ‰์  ํ˜น์€ ์ •์„ฑ์  ์†Œ๋ณ€์ด๋‚˜ ํ˜ˆ์•ก์˜ ์ž„์‹  ๊ฒ€์‚ฌ๊ฒฐ๊ณผ๋ฅผ ํ™•์ธํ•ด์•ผ ํ•œ๋‹ค.
โ€ข
ํŠนํžˆ ํ˜ˆ์—ญํ•™์ ์œผ๋กœ ๋ถˆ์•ˆ์ •ํ•œ ๊ฐ€์ž„๊ธฐ ์—ฌ์„ฑ์—์„œ๋Š” ectopic pregnancy๋ฅผ ๋ฐ˜๋“œ์‹œ ์˜์‹ฌํ•ด์•ผ ํ•œ๋‹ค.

G2. Elderly patients

โ€ข
๋น„๋ก ๋‚˜์œ ์˜ˆํ›„(84์„ธ ์ด์ƒ, bandemia, free air)์™€ ๊ด€๋ จ๋œ ํ™•์‹คํ•œ ๋ณ€์ˆ˜๋“ค์ด๋‚˜, ์ˆ˜์ˆ ์  ์ฒ˜์น˜๊ฐ€ ํ•„์š”ํ•œ ๋‹ค๋ฅธ ๊ฒฝ์šฐ (์ €ํ˜ˆ์••, ๋น„์ •์ƒ์  ์žฅ์Œ, ์‹ฌํ•˜๊ฒŒ ๋Š˜์–ด๋‚˜ ์žˆ๋Š” bowel loop, ๊ทน๋‹จ์ ์ธ leukocytosis)๊ฐ€ ์—†๋” ๋”๋ผ๋„ ์‹ฌ๊ฐํ•œ ์งˆํ™˜์„ ๋ฐฐ์ œํ•  ์ˆ˜๋Š” ์—†๋‹ค.
โ€ข
๋…ธ์ธ ๋ณตํ†ตํ™˜์ž์—์„œ ์ง„๋‹จ์ด ๋ถˆํ™•์‹คํ•˜๊ฑฐ๋‚˜ f/u์ด ์ž˜ ๋˜์ง€ ์•Š์„ ๊ฒƒ ๊ฐ™์€ ๊ฒฝ์šฐ์—๋Š” imaging/admission/observation ํ•  ๊ฒƒ์„ ๊ฐ•๋ ฅํžˆ ์ถ”์ฒœํ•œ๋‹ค (GE๋‚˜ NE์—์„œ ์ด๋Ÿฐ ๊ฐœ๋…์ด ์—†์Œ)
1.
Bariatric surgery patients
2.
Epiploic appendagitis

H. The postop. patient with acute abdominal pain

1.
Ileus and early postoperative bowel obstruction
2.
Acute urinary retention
Table 71-4 (Imaging of) Common diagnoses for acute abdominal pain in adults
1.
Appendicitis - CT preferred in adults and nonpregnant women
2.
Biliary colic - US : 86-96% sensitivity, 78-98% specificity
3.
Bladder outlet obstruction - bedside US
4.
Bowel obstruction - plain films : 77% sensitivity, CT 93% sensitivity
5.
Cholecystitis - US : 91% sensitivity hepatobiliary iminodiacetic acid scan : 97% sensitivity, 90% specificity
6.
Diverticulitis - CT : sensitivity 93-100%, specificity 100%
7.
Epiploic appendagitis : CT
8.
Mesenteric arterial occlusion - selective CT angiography : 96% sensitivity
9.
Mesenteric venous thrombosis - contrast-enhanced CT
10.
Mesenteric ischemia(nonocclusive) - angiography
11.
Pancreatitis - US may show edema, CT : 78% sensitivity, 86% specificity
12.
Perforated viscus - upright chest x-ray : 80% sensitivity for free air
13.
Ovarian torsion - pelvic US with doppler flow
14.
Renal/ureteral colic - CT
15.
Ruptured ectopic pregnancy - transvaginal US
16.
Ruptured/leaking abdominal aortic aneurysm - bedside US 100% sensitivity